1. Bi, Yanping, Liu, Jie, Qin, Songbing, Yang, Haihua, Zhou, Suna. 2024. CDKL3 shapes immunosuppressive tumor microenvironment and initiates autophagy in esophageal cancer. In Frontiers in immunology, 15, 1295011. doi:10.3389/fimmu.2024.1295011. https://pubmed.ncbi.nlm.nih.gov/38562942/
2. Liu, Zanhua, Xu, Dafeng, Zhao, Yongbo, Zheng, Jing. 2010. Non-syndromic mild mental retardation candidate gene CDKL3 regulates neuronal morphogenesis. In Neurobiology of disease, 39, 242-51. doi:10.1016/j.nbd.2010.03.015. https://pubmed.ncbi.nlm.nih.gov/20347982/
3. Pang, Zhongqiu, Zhang, Hui, Zheng, Shaoqin, Zheng, Qianqian, Sheng, Ren. 2024. HNF4α-CDKL3 axis restricts MASLD progression by targeting FoxO1 via noncanonical phosphorylation. In Hepatology (Baltimore, Md.), , . doi:10.1097/HEP.0000000000001147. https://pubmed.ncbi.nlm.nih.gov/39658857/
4. Dubos, Aline, Pannetier, Solange, Hanauer, André. . Inactivation of the CDKL3 gene at 5q31.1 by a balanced t(X;5) translocation associated with nonspecific mild mental retardation. In American journal of medical genetics. Part A, 146A, 1267-79. doi:10.1002/ajmg.a.32274. https://pubmed.ncbi.nlm.nih.gov/18412109/
5. He, Aina, Ma, Lanjing, Huang, Yujing, Sheng, Ren, Xiang, Dongxi. 2020. CDKL3 promotes osteosarcoma progression by activating Akt/PKB. In Life science alliance, 3, . doi:10.26508/lsa.202000648. https://pubmed.ncbi.nlm.nih.gov/32234750/
6. Cui, Yong, Yang, Zhigang, Wang, Hongxiang, Chen, Juxiang, Xu, Tao. 2021. Identification of CDKL3 as a critical regulator in development of glioma through regulating RRM2 and the JNK signaling pathway. In Cancer science, 112, 3150-3162. doi:10.1111/cas.15010. https://pubmed.ncbi.nlm.nih.gov/34097336/
7. Li, Rong, Chai, Linyan, Lei, Lei, Guo, Rong, Wen, Xiulin. 2023. CDKL3 Promotes Non-small Cell Lung Cancer by Suppressing Autophagy Via Activation of PI3K/Akt/mTOR Pathway. In Molecular biotechnology, 65, 1421-1431. doi:10.1007/s12033-023-00656-8. https://pubmed.ncbi.nlm.nih.gov/36630073/
智鼠故事 
